JMA Calls for Investigation into Increasing Cases of Off-Label Use of GLP-1 Agents

JMA Vice President Satoshi Imamura Satoshi Imamura, vice president of the Japan Medical Association (JMA), said on March 2 that a growing number of medical institutions have been using GLP-1 receptor agonists, which are approved to treat diabetes, off-label to...read more